Circulation · 1985 · 50 citations · 14 references
MedicineCardiologyPharmacologyCardiovascular PharmacotherapyClinical PharmacologyHemodynamic ManagementCardiac MedicationsCardiac PharmacotherapyCardiomyopathy PharmacotherapyCardiovascular PharmacologyHemodynamic PharmacologyBlood PressureCardiac IndexDiastolic Function EvaluationHeart RateHemodynamic Drug EffectsHypertrophic Cardiomyopathy Drug TherapyNifedipine TherapyVascular Resistance
The hemodynamic effects of sublingual nifedipine were examined in 36 patients with hypertrophic cardiomyopathy. Twenty-one patients were initially given 20 mg and 15 patients were given 10 mg of the drug; 30 min after this first dose 26 patients received 10 mg and one patient 20 mg as a second dose. Hemodynamic findings in patients who received different doses of the drug were similar. Peak effects included an increase in heart rate from 79 +/- 12 to 91 +/- 14 (mean +/- 1 SD) beats/min (p less than .01), and a decrease in mean blood pressure from 89 +/- 12 to 77 +/- 10 mm Hg (p less than .01). Cardiac index increased after nifedipine (2.8 +/- 0.6 to 3.3 +/- 0.8 liters/min/m2; p less than .01); stroke volume index, however, did not change (36 +/- 7 to 36 +/- 8 ml/beat/m2; NS). Peripheral vascular resistance index fell significantly from 822 +/- 261 to 610 +/- 197 dynes X sec X cm-5 (p less than .01). Overall, left ventricular outflow tract gradient (LVOTG) did not change in patients with significant (greater than or equal to 30 mm Hg) basal LVOTG (75 +/- 22 to 83 +/- 22 mm Hg; NS), but it increased significantly in those six patients in whom peripheral vascular resistance fell by 25% or more (73 +/- 28 to 99 +/- 22 mm Hg; p less than .05).(ABSTRACT TRUNCATED AT 250 WORDS)
14
Treatment of hypertrophic obstructive cardiomyopathy with verapamil.
M. Kaltenbach, R. Hopf, G. Kober et al. · Heart · 1979 · 213 citations · Full text